Overuse of antidepressants in a nationally representative adult patient population in 2005

Psychiatric Services

Volumn 62, Issue 7, 2011, Pages 720-726

  Conti, Rena ^a   Busch, Alisa B ^b   Cutler, David M ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PRESCRIPTION DRUG;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DEPRESSION; DRUG ABUSE; DRUG COST; DRUG EFFICACY; HEALTH CARE QUALITY; HEALTH SURVEY; HOUSEHOLD; HUMAN; MEDICAL LITERATURE; MENTAL HEALTH; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OFF LABEL DRUG USE; PREDICTOR VARIABLE; SAMPLE; SAMPLE SIZE; SELF REPORT; SOCIOECONOMICS; STRATIFIED SAMPLE; UNITED STATES;

EID: 79960028188     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.62.7.pss6207_0720     Document Type: Article

References (49)

1. Shrank WH, Asch SM, Adams J, at al: The quality of pharmacologic care for adults in the United States. Medical Care 44:936-945, 2006 (Pubitemid 44454571)
2. Radley DC, Finkelstein SN, Stafford RS: Off-label prescribing among office-based physicians. Archives of Internal Medicine 166:1021-1026, 2006
3. Briesacher B, Limcangco MR, Simoni-Wastila L, et al: The quality of antipsychotic drug prescribing in nursing homes. Archives of Internal Medicine 165:1280-1285, 2005 (Pubitemid 40989593)
4. Goulding MR: Inappropriate medication prescribing for elderly ambulatory care patients. Archives of Internal Medicine 164:305-312, 2004
5. Sebalt RJ, Petrie A, Goldsmith CH, et al: Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study. American Journal of Managed Care 10:742-750, 2005 (Pubitemid 39518520)
6. Naunton M, Peterson GM, Blease MD: Overuse of proton pump inhibitors. Journal of Clinical Pharmacy and Therapeutics 25:333-340, 2000 (Pubitemid 32002877)
7. Kerr EA, McGlynn EA, Van Vorst KA, et al: Measuring antidepressant prescribing practice in a health care system using administrative data: implications for quality measurement and improvement. Joint Commission Journal on Quality and Safety 26:203-216, 2000
8. Jureidini J, Tonkin A: Overuse of antidepressant drugs for the treatment of depression. CNS Drugs 20:623-632, 2006 (Pubitemid 44141490)
9. De Smet BD, Fendrick AM, Stevenson JG, et al: Over and under-utilization of cyclooxygenase-2 selective inhibitors by primary care physicians and specialists: the Tortoise and the Hare revisited. Journal of General Internal Medicine 21:694-697, 2006 (Pubitemid 43973552)
10. Chassin MR, Galvin RW: The urgent need to improve health care quality: Institute of Medicine National Roundtable on Health Care Quality. JAMA 280:1000-1005, 1998
11. Druss BF, Wang PS, Sampson NA, et al: Understanding mental health treatment in persons without mental diagnoses: results from the National Comorbidity Survey Replication. Archives of General Psychiatry 64:1196-1203, 2007 (Pubitemid 47529344)
12. Office of the Actuary: Estimated Financial Effects of the "Patient Protection and Affordable Care Act," as Amended. Washington, DC, Centers for Medicare and Medicaid Services, Apr 22, 2010
13. Pincus HA, Tanelian TL, Marcus SC: Prescribing trends in psychotropic medication. JAMA 279:526-531, 1998
14. Olfson M, Marcus SC: National patterns in antidepressant medication treatment. Archives of General Psychiatry 66:848-856, 2009
15. Hanlon JT, Handler SM, Castle NG: Antidepressant prescribing in US nursing homes between 1996 and 2006 and its relationship to staffing patterns and use of other psychotropic medications. Journal of the American Medical Directors Association 11:320-324, 2010
16. Moncrieff J, Kirsch I: Efficacy of antidepressants in adults. British Medical Journal 331:155-157, 2005 (Pubitemid 41003178)
17. Kirsch I, Moore T, Scoboria A, et al: The emperor's new drugs: an analysis of antidepressant medication submitted to the US Food and Drug Administration. Prevention and Treatment 5:article 23, 2002
18. De Lima MS, Hotopf M: Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence. Drug Safety 26:55-64, 2003 (Pubitemid 36092276)
19. Treatment of Depression - Newer Pharmacotherapies: Evidence Report/Technology Assessment. No 7. Rockville, Md, Agency for Health Care Policy and Research, Mar 1999
20. Bridge JA, Iyengar S, Salary CB, et al: Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a metaanalysis of randomized controlled trials. JAMA 297:1683-1696, 2007
21. Gibbons R, Hur K, Bhaumik D, et al: The relationship between antidepressant medication use and rate of suicide. Archives of General Psychiatry 62:165-172, 2005 (Pubitemid 40189132)
22. Potask J: Antidepressants: who needs them? ABC News, July 18, 2007. Available at www.abcnews.go.com/Health/Depression/story?id=3389691&page=1
23. Kessler RC, Demler O, Frank RG, et al: Prevalence and treatment of mental disorders, 1990 to 2003. New England Journal of Medicine 352:2515-2523, 2005
24. Jencks SF: Recognition of mental distress and diagnosis of mental disorders in primary care. JAMA 253:1903-1907, 1985
25. Perez-Stable EJ, Miranda J, Munoz RF, et al: Depression in medical outpatients: under-recognition and misdiagnosis. Archives of Internal Medicine 150:1083-1088, 1990 (Pubitemid 20155335)
26. Andrews G, Henderson S: Unmet Need in Psychiatry: Problems, Resources, Responses. Cambridge, England, Cambridge University Press, 2000
27. Tierney R, Melfi CA, Signa W, et al: Antidepressant use and use patterns in naturalistic settings. Drug Benefit Trends 6:7-12, 2000
28. Regier DA, Narrow WE, Rae DS, et al: The de facto US mental and addictive disorders service system: epidemiological catchment area prospective 1-year prevalence rates of disorders and services. Archives of General Psychiatry 50:85-94, 1993 (Pubitemid 23059313)
29. Kessler RC, McGonagle KA, Zhao S, et al: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Archives of General Psychiatry 51:8-19, 1994 (Pubitemid 24028993)
30. Aoun S, Pennebaker D, Wood C: Assessing population need for mental health care: a review of approaches and predictors. Mental Health Services Research 6:33-46, 2004 (Pubitemid 38239678)
31. Sclar DA, Robison LM, Skaer TL, et al: What factors influence the prescribing of antidepressant pharmacotherapy? An assessment of national office-based encounters. International Journal of Psychiatry in Medicine 28:407-419, 1998 (Pubitemid 29144681)
32. Sleath B, Shih YC: Sociological influences on antidepressant prescribing. Social Science and Medicine 56:1335-1344, 2003 (Pubitemid 36216330)
33. Stata Statistical Software: Release 9. College Station, Tex, StataCorp, 2005
34. Cohen SB: Design and Methods of the Medical Expenditure Panel Survey Household Component. MEPS Methodology Report No 1. AHCPR publication 97-0026. Rockville, Md, Agency for Healthcare Research and Quality, 2005
35. MEPS-HC Sample Design and Collection Process. Rockville, Md, Agency for Healthcare Research and Quality. Available at www.meps.ahrq.gov/survey-comp/hc- data-collection.jsp. Accessed Jan 2010
36. Machlin S, Cohen J, Elixhauser A, et al: Sensitivity of household reported medical conditions in the Medical Expenditure Panel Survey. Medical Care 47:618-625, 2009
37. MEPS HC-097: 2005 Full Year Consolidated Data File, November 2007. Rockville, Md, Agency for Healthcare Research and Quality. Available at meps.ahrq.gov/mepsweb/data-stats/download-data/pufs/h97/h97doc.pdf#x
38. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC, Public Health Service, US Dept of Health and Human Services, 1988
39. Lexicon Plus. Denver, Colo, Cerner Multum, Inc, 2006. Available at www.multum.com/Lexicon.htm. Accessed Nov 2006
40. Physicians' Desk Reference, 60th ed. Monvale, NJ, Medical Economics Co, 2006
41. Qato DM, Lindau ST, Conti RM, et al: Racial and ethnic disparities in cardiovascular medication use among older adults in the United States. Pharmacoepidemiology and Drug Safety 19:834-842, 2010
42. United States Pharmacopeia: National Formulary, online version 2002, 2003, 2004, 2005, 2006. Rockville, Md, US Pharmacopeia Available at www.usp.org/USP-NF. Accessed July 30, 2009
43. Payment for covered outpatient drugs and biologicals. Federal Register 69:55763, 2004
44. DRUGDEX System, CD-ROM, version 5.1. Thomson Micromedex.
45. Godfrey RG: A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes. Archives of Internal Medicine 156:1047-1052, 1996
46. Ware JE, Kosinski M, Keller SD: SF-12: How to Score the SF-12 Physical and Mental Health Summary Scales, 2nd ed. Boston, New England Medical Center, Health Institute, 1995
47. Gill SC, Butterworth P, Rodgers B, et al: Validity of the mental health component scale of the 12-Item Short-Form Health Survey (MCS-12) as measure of common mental disorders in the general population. Psychiatry Research 152:63-71, 2007 (Pubitemid 47030684)
48. Hosmer D, Lemeshow S: Applied Logistic Regression. New York, Wiley, 1989
49. Rost K, Smith GR, Matthews DB, et al: The deliberate misdiagnosis of major depression in primary care. Archives of Family Medicine 3:333-337, 1994